405 filings
Page 4 of 21
424B3
9mi0vplzzl4ugburb
7 Jan 19
Prospectus supplement
8:17am
424B3
cut9524o51 zgripa
7 Jan 19
Prospectus supplement
8:14am
6-K
we0 eyte3wg
7 Jan 19
Intellipharmaceutics Announces Research and Development Program for a Pipeline of Pharmaceutical Cannabidiol Based Products
8:09am
424B3
v7qpschh9ogwo3j1
6 Dec 18
Prospectus supplement
11:17am
424B3
d27j25jeq0bfveo7j68
6 Dec 18
Prospectus supplement
11:12am
6-K
dwgg6762ys
5 Dec 18
Primary Document
12:00am
SC 13G
z27e1202wpb
30 Nov 18
Intellipharmaceutics International Inc.
5:27pm
424B3
5azj mepc38pifs
28 Nov 18
Prospectus supplement
2:42pm
424B3
1o4 pll3k35ca8nl90
28 Nov 18
Prospectus supplement
2:39pm
6-K
1c4sm h0esen80qq
27 Nov 18
Intellipharmaceutics Announces FDA Final Approval of Generic Effexor® XR
5:14pm
424B3
mumu3qcdr sqnmn
27 Nov 18
Prospectus supplement
3:36pm
424B3
qkg83b9b
27 Nov 18
Prospectus supplement
3:22pm
424B3
1f95jk6y 4bj41
27 Nov 18
Prospectus supplement
3:18pm
424B3
4mteo5ar03 gd97yews6
27 Nov 18
Prospectus supplement
3:15pm
6-K
ibf6omnneom
27 Nov 18
Primary Document
8:10am
6-K
9rsfmffcflk364
26 Nov 18
Intellipharmaceutics Announces Receipt of Nasdaq Notice
9:37pm
424B3
9bnhb2i
21 Nov 18
Prospectus supplement
5:24pm
424B3
jg4dk
21 Nov 18
Prospectus supplement
5:22pm
6-K
ixaac0r61lv
21 Nov 18
Primary Document
4:30pm
424B3
q4pnann4
21 Nov 18
Prospectus supplement
11:56am